OpenBilldrug price receipt

NADAC week of 2026-10-14

ANASTROZOLE 1 MG TABLET

For 30 tablets

Pharmacies pay

$4.25 filed

30 × $0.14163 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$8.75 filed

30 × $0.29182 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

2.1× estimated

Medicare paid 2.1× what pharmacies pay.

Part D averages every strength and form sold under “Anastrozole” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$9.89 estimated

$4.25 + $0.64 (15%) + $5.00 fee per fill = $9.89

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

ANASTROZOLE 1 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “anastrozole” and “anastrozole tablets”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as “tablet, film coated”, “tablet” and “tablet, coated” and its route as oral.

FDA lists 10 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Accord Healthcare Inc. and Avet Pharmaceuticals Inc.

FDA’s Established Pharmacologic Class for it is Aromatase Inhibitor.

The NADAC file of 2026-10-14 prices it under 21 NDCs (National Drug Codes); the FDA directory lists 19 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $4.25 for 30 tablets (30 × $0.14163 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 10 labelers

LabelerNDCsPharmacies pay per unit
Accord Healthcare Inc.3$0.14163 per EA filed
Avet Pharmaceuticals Inc3$0.14163 per EA filed
Breckenridge Pharmaceutical, Inc.3$0.14163 per EA filed
Aurobindo Pharma Limited2$0.14163 per EA filed
BluePoint Laboratories2$0.14163 per EA filed
Chartwell RX, LLC2$0.14163 per EA filed
American Health Packaging1$0.14163 per EA filed
AvPAK1$0.14163 per EA filed
Teva Pharmaceuticals USA, Inc.1$0.14163 per EA filed
Zydus Pharmaceuticals USA Inc.1$0.14163 per EA filed
Not listed as a package in the FDA directory2$0.14163 per EA filed
All 21 NDCs, with labeler and price
  • 00093-7536-56 · Teva Pharmaceuticals USA, Inc. · $0.14163 per EA · eff. 2026-09-23 filed
  • 16729-0035-10 · Accord Healthcare Inc. · $0.14163 per EA · eff. 2026-09-23 filed
  • 16729-0035-15 · Accord Healthcare Inc. · $0.14163 per EA · eff. 2026-09-23 filed
  • 16729-0035-16 · Accord Healthcare Inc. · $0.14163 per EA · eff. 2026-09-23 filed
  • 23155-0857-03 · Avet Pharmaceuticals Inc · $0.14163 per EA · eff. 2026-09-23 filed
  • 23155-0857-05 · Avet Pharmaceuticals Inc · $0.14163 per EA · eff. 2026-09-23 filed
  • 23155-0857-09 · Avet Pharmaceuticals Inc · $0.14163 per EA · eff. 2026-09-23 filed
  • 50268-0075-11 · not listed as a package in the FDA directory · $0.14163 per EA · eff. 2026-09-23 filed
  • 50268-0075-15 · AvPAK · $0.14163 per EA · eff. 2026-09-23 filed
  • 51991-0620-10 · Breckenridge Pharmaceutical, Inc. · $0.14163 per EA · eff. 2026-09-23 filed
  • 51991-0620-33 · Breckenridge Pharmaceutical, Inc. · $0.14163 per EA · eff. 2026-09-23 filed
  • 51991-0620-90 · Breckenridge Pharmaceutical, Inc. · $0.14163 per EA · eff. 2026-09-23 filed
  • 59651-0236-30 · Aurobindo Pharma Limited · $0.14163 per EA · eff. 2026-09-23 filed
  • 59651-0236-90 · Aurobindo Pharma Limited · $0.14163 per EA · eff. 2026-09-23 filed
  • 60687-0112-11 · not listed as a package in the FDA directory · $0.14163 per EA · eff. 2026-09-23 filed
  • 60687-0112-21 · American Health Packaging · $0.14163 per EA · eff. 2026-09-23 filed
  • 62135-0490-30 · Chartwell RX, LLC · $0.14163 per EA · eff. 2026-09-23 filed
  • 62135-0490-90 · Chartwell RX, LLC · $0.14163 per EA · eff. 2026-09-23 filed
  • 68001-0155-04 · BluePoint Laboratories · $0.14163 per EA · eff. 2026-09-23 filed
  • 68001-0155-08 · BluePoint Laboratories · $0.14163 per EA · eff. 2026-09-23 filed
  • 68382-0209-06 · Zydus Pharmaceuticals USA Inc. · $0.14163 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

1 other product in the NADAC file shares an FDA nonproprietary name with ANASTROZOLE 1 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
ANASTROZOLE 1 MG TABLET this page
generic · tablet, film coated / tablet / tablet, coated
$0.14163 per EA filed
eff. 2026-09-23
$0.29182 per EA filed
Part D 2024 average
ARIMIDEX 1 MG TABLET
brand · tablet
$52.86163 per EA filed
eff. 2026-09-23
$50.35184 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 21 NDCs’ NADAC prices is $0.14163 per EA filed.

Of the 5 other products in FDA’s Aromatase Inhibitor class priced per EA, 5 have a higher middle NADAC price and 0 a lower one. The one in the middle is FEMARA 2.5 MG TABLET, at $27.11602 per EA filed (eff. 2026-01-07).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-07, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $8.75 for 30 tablets, at an average of $0.29182 per EA in 2024 (2024-01-01 to 2024-12-31) for “Anastrozole”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 1,702,914 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for ANASTROZOLE 1 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Anastrozole / Anastrozole: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.